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Abstract
Approximately 11% the Clostridium difﬁcile genome is made up of mobile genetic elements which have a profound effect on the biology of
the organism. This includes transfer of antibiotic resistance and other factors that allow the organism to survive challenging environments,
modulation of toxin gene expression, transfer of the toxin genes themselves and the conversion of non-toxigenic strains to toxin producers.
Mobile genetic elements have also been adapted by investigators to probe the biology of the organism and the various ways in which these have
been used are reviewed.
© 2015 The Authors. Published by Elsevier Masson SAS on behalf of Institut Pasteur. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
Approximately 11% of the Clostridium difﬁcile genome is
made up of mobile genetic elements (MGEs) [1] which pro-
vides the bacterium with a remarkable genetic plasticity.
However the exact role of the mobile genome in the organism's
biology, evolution and pathogenicity is only now beginning to
be understood.
MGEs are highly heterogeneous and here we will deﬁne
them in the loosest possible terms as any region of nucleic acid
that can move from one part of a genome to another or be-
tween genomes. By this deﬁnition, MGEs range from the
simple insertion sequences which contain only the genetic
information required for movement from one part of the
genome to another, to bacteriophage, large conjugative trans-
posons and mega plasmids which are complex genomes in
themselves. In this review we will provide examples of some
of these genetic elements and discuss the mechanisms of
horizontal gene transfer and the consequent biological effects
on the host cell.
2. Plasmids
Plasmids are extra chromosomal genetic elements which
range in size from very small, around 1.5 kb to mega plasmids
which can reach the size of bacterial genomes e.g. [2].I nC.
difﬁcile, plasmids have been identiﬁed in several different
strains [1,3e5]. To our knowledge no phenotype has been
found to be conferred on C. difﬁcile by a naturally occurring
plasmid. However, naturally occurring C. difﬁcile plasmids
have been used to generate vectors for the genetic manipula-
tion of the organism [6,7].
The plasmids used as the basis for C. difﬁcile genetic
manipulation are small and cryptic and contain only the ge-
netic information required for their replication and mainte-
nance. The subsequent addition of Escherichia coli origins of
replication and origins of transfer allowed the construction of
shuttle vectors that can replicate in both C. difﬁcile and E. coli
and can be mobilised from E. coli to C. difﬁcile [6,7]. Vectors
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sively modiﬁed to provide a range of research tools for the
bacterium [8,9].
3. IS sequences
These are simple MGEs, containing just the genetic infor-
mation required to translocate from one part of the genome to
another. However IS elements in C. difﬁcile have not been
investigated to date and they will not be discussed further here.
However IStrons which are a hybrid element consisting of an
IS element and a group I intron are discussed below.
4. The mobile introns
Introns were ﬁrst discovered in 1977 when it was found that
eukaryotic genes were split, i.e. that the coding region was
interrupted by non-coding sequences (introns) that were
spliced out of the RNA transcripts before being translated
[10,11]. At the time this was a surprising ﬁnding that repre-
sented a paradigm shift in our understanding of biology.
Initially it was thought that bacteria and their viruses did not
contain introns however this notion was shown to be incorrect
with the ﬁnding of an intron in a phage genome [12]. Subse-
quently introns have been found in many different bacteria,
nearly always found in association with mobile DNA,
although they are rare in prokaryotes compared to eukaryotes.
Bacterial introns are classiﬁed into either group I or group II
according to their conserved secondary structure [13].
4.1. Group II introns
The ﬁrst intron found in C. difﬁcile was a group II intron
and it was contained within orf14 of the conjugative trans-
poson, Tn5397 [14]. Group II introns often contain an ORF
encoding a multifunctional protein made up of maturase,
endonuclease and reverse transcriptase domains. This multi-
functional protein becomes part of a riboprotein complex in
conjunction with the intron-encoded RNA. This riboprotein
complex is required for effective splicing and the riboprotein
can catalyse intron transposition [13]. Work in our laboratory
has shown that the C. difﬁcile intron is capable of splicing and
that the intron-encoded protein is required for this process
[15]. Transposition of this element has not been demonstrated,
but group II introns have been found in other C. difﬁcile ele-
ments suggesting that they are capable of transposition [16].
The contribution of the mobile group II introns to C. difﬁcile
biology has not been determined but, as one has been shown to
splice perfectly from its host gene [15] and has a small size,
their biological costs are likely to be low. Group II introns may
have a role in regulation as differential splicing can allow
alternative proteins to be produced. This has not been demon-
strated in C. difﬁcile but in Clostridium tetani, a group II intron
has been characterised and shown to undergo alternative
splicing to produce different isoforms of surface layer proteins
[17]. Group II introns have been used in biotechnological ap-
proaches forming the basis of the TargeTron which has been
used for making targeted gene knock-outs [18]. TargeTrons
adapted for the clostridia have been termed ‘clostrons’ [8].
4.2. IStrons
IStronsarehybridgeneticelementscombiningagroupIintron
and an insertion sequence [19]. The whole element is capable of
both splicing out of primary transcripts and transposing to new
genomic sites. These elements are relatively wide-spread in C.
difﬁcile. Analysis of the splicing reaction in IStrons has shown
thattheycanhavealternativesplicesitesleadingtotheproduction
of variant proteins [19]. As IStrons have beenfound insertedinto
the C. difﬁcile toxin A gene, alternative splicing could produce
alternative toxins [19], although IStron mediated toxin variation
has not yet been demonstrated.
5. Conjugative and mobilisable transposons
Conjugative transposons (CTns) also called Integrative
Conjugative Elements (ICE), are genetic elements that are
capable of transferring themselves from a donor cell to a
recipient using a conjugation-like mechanism. Unlike plas-
mids these elements do not normally contain an origin of
replication so in order to survive they must be integrated into a
replicon. Mobilisable transposons (MTns) can also be trans-
ferred by a conjugation-like mechanism but these elements
lack the genes required for conjugation and use those of CTns
or conjugative plasmids that are present in the same cell. For a
detailed discussion of the properties of these types of ele-
ments, the reader is referred to the following recent reviews
[20e23]. Here we will discuss what is known about the CTns
and MTns from C. difﬁcile.
Several DNA sequencing projects have shown that C.
difﬁcile contains a plethora of putative CTns and MTns and
some of these are proven to be active and capable of con-
jugative transfer [1,16,24,25]. The typical genetic organisation
of these elements is that they contain regions required for
integration and excision, conjugation (in the case of CTns, this
is absent in MTns), regulation and an accessory region. The
latter usually contains genes which are thought to allow the
bacterium to survive in particularly challenging environments,
such as antibiotic resistance genes and ABC transporters [16].
Some CTns have been shown to encode sigma factors;
whether these are required for regulation of the CTn itself or
have a more global role in the host biology is not known.
Surprisingly, despite the large number of CTns and MTns
detected in different strains of C. difﬁcile, very few have been
studied in detail. Although bioinformatics analysis has led to
predictions of how these elements might affect the biology of
C. difﬁcile, there is little experimental evidence. The following
section will discuss what is known about how these elements
affect the biology of their host.
5.1. Tn5397 and Tn916
Tn5397 is the best understood of the C. difﬁcile CTns. It
was originally discovered in strain 630 where it conferred
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between C. difﬁcile strains and to and from Bacillus subtilis
and Enterococcus faecalis and the element has also been found
in Streptococcus spp. [27e29]. The element is 21 kb in size
and is very closely related to Tn916, the paradigm for this
family of MGEs [30]. The ends of the elements are very
different and Tn5397 encodes a large serine recombinase,
TndX, responsible for integration and excision [31]. TndX
directs the element into two highly preferred insertion sites in
C. difﬁcile R20291 [32]. However in B. subtilis there are no
obvious preferred insertion sites apart from a central GA
dinucleotide which is always present in the target site.
Both Tn916 and Tn5397 confer tetracycline resistance on C.
difﬁcile b u ti nc o n t r a s tt oT n 916, which inserts into multiple
regions of the genome (see below), Tn5397 inserts into DNA
predicted to encode a domain initially termed Fic (ﬁlamentation
processes induced by cAMP). This was characterised in E. coli
where mutation of the ﬁc gene resulted in ﬁlamentous growth
[33]. Latter work showed that Fic domains are ubiquitous in all
domains of life and they can be present in a myriad of different
proteins, reviewed in [34]. Proteins containing Fic domains are
involved in post-translational modiﬁcation of their targets via
UMPylation, AMPylation, phosphorylation, or phosphocholi-
nation [34]. In order to determine if the sequence of the C.
difﬁcile Fic encoding domain itself is responsible for the
remarkable targeting of this region by Tn5397 we cloned it into
B. subtilis and showed that Tn5397 always entered the genome
in the cloned sequence encoding the Fic domain, demonstrating
that if this region is present it is used by Tn5397 [32].B a n d
shift assays showed that this was most likely a result of TndX
showing preferential binding to the sequence in the Fic
encoding domain [32]. It is intriguing that TndX has evolved to
target Fic encoding domains; perhaps because these are ubiq-
uitous in all forms of life they provide a suitable target for a
promiscuous CTn.
Tn916 has also been found in C. difﬁcile and transferred
into this organism from B. subtilis [35]. In contrast to Tn5397,
Tn916 contains genes encoding a tyrosine recombinase and an
excisionase which are responsible for integration and excision
of the element. This difference results in Tn916 having the
ability to insert into multiple sites in the C. difﬁcile genome
although it does have a preferred consensus site which is
present in the C. difﬁcile genome 10
5 times [35]. This
consensus is present more times in intergenic regions than
within ORFs [35].
Tn916 has also been used as a tool for the investigation of
C. difﬁcile biology, both for mutagenesis [35] and for gene
cloning in the organism [7,36,37]. As a tool for mutagenesis,
the site preferences noted above for the element is a disad-
vantage. Another system for C. difﬁcile transposon mutagen-
esis has been developed based on a Mariner transposon and it
is likely that this system will be the mutagenesis tool of choice
as it does not appear to suffer from the site speciﬁcity of
Tn916 [9]. However, since the ﬁrst report of a C. difﬁcile
Mariner system in 2010, no large scale mutagenesis studies
have been reported suggesting that Tn916 may have to be
revisited as a tool for mutagenesis.
Tn916 was the ﬁrst genetic element used for successful
cloning in C. difﬁcile and it made use of the fact that cargo
DNA can be added to the region of Tn916 upstream of the
tet(M) gene without affecting its conjugative ability. A vector
that contained regions of homology to Tn916 was designed
and this was transformed into B. subtilis and the recombinant
transposon could be transferred by conjugation to C. difﬁcile
[36]. Cloning into Tn916 has been used to investigate the role
of the virR [7] cwp66 [37] and the skin element (see below)
[38].
5.2. Tn4453a and Tn4453b
Tn4453a and Tn4453b were initially found in C. difﬁcile
strain W1 where they conferred resistance to chloramphenicol
[39]. These two elements only differ from each other by a few
base pairs and are very closely related to the Clostridium
perfringens MTn, Tn4451 [40]. When Tn4451 was cloned in
E. coli it could be mobilised by plasmid RP4 to C. perfringens
[41]. Although the C. difﬁcile MTns could not be transferred
in the laboratory, the fact that they are very closely related to a
proven MTn suggests that they are likely to be capable of
mobilisation. Genetic elements related to Tn4453 and Tn4451
have been found contained within the large C. difﬁcile CTn,
Tn6103 [16] Fig. 1. One of these elements, Tn6104, could
excise from Tn6103. Unlike Tn4453 which contains the
chloramphenicol resistance gene catD, Tn6104 has genes
predicted to encode a transcriptional regulator, a two compo-
nent regulatory system, an ABC transporter, three sigma fac-
tors and a putative toxin-antitoxin system [16]. The role of
these genes in C. difﬁcile biology remains to be determined.
5.3. Tn5398
Tn5398 was originally discovered because it was respon-
sible for transferable macrolide, lincomycin, streptogramin B
(MLS) resistance, encoded by the erm(B) gene [42,43]. The
element was capable of transfer between C. difﬁcile and B.
subtilis [42] and between C. difﬁcile and Staphylococcus
aureus [43]. Comparison of the sequences in transconjugant
and recipients, allowed the ends of the element to be deter-
mined showing that it was 9.6 kb in length [44].T n 5398 is a
rather unusual element as it does not contain any obvious
recombinases and no circular forms have been found. However
the element does contain putative origins of transfer (oriT)
sites. There are at least two ways, which are not mutually
exclusive, in which Tn5398 could transfer. One of the CTns
present in the donor strain could provide integration/excision
functions to generate a circular intermediate molecule which is
then nicked at the oriT site and transferred to a recipient using
the conjugation functions of a CTn; integration in the recipient
could either be by homologous recombination or by using a
site-speciﬁc recombinase in the recipient. The other possibility
is that the element is not excised but that a portion of the
genome is transferred to the recipient and integrates into the
recipient chromosome by homologous recombination. This
process is analogous to high frequency recombination (hfr)
363 P. Mullany et al. / Research in Microbiology 166 (2015) 361e367seen when the E. coli F-factor is integrated into the chromo-
some and mobilises transfer of the whole chromosome to a
suitable recipient. In this case, one of the integrated CTns
could be mediating the transfer; this would require that the
mobilising CTn does not excise. We have proposed that this is
the mechanism responsible for transfer of the PaLoc, see
below. It should be noted that the term hfr for these types of
transfer events is confusing as they are not high frequency
recombination events; we propose that the term chromosomal
transfer and recombination (CTaR) is used instead.
A genetic element that also encodes resistance to MLS
antibiotics mediated by an ermB gene has been found in C.
difﬁcile. This element, Tn6194, has a conjugation region that
is closely related to that of Tn916 but contains an accessory
region that is related to Tn5398 [45]. This modular composi-
tion is commonly observed amongst the MGEs in C. difﬁcile.
AT n 6194-like element has been shown to be capable of
transfer between C. difﬁcile strains and to E. faecalis [45].
6. The skin
Cd element
The sigK intervening sequence (skin) element was origi-
nally identiﬁed as a prophage-like sequence integrated into the
B. subtilis sigK gene [46]. When B. subtilis sporulates, the
element excises only in the mother cell, resulting in an intact
sigK gene and production of the sigma factor K which is
required for the sporulation cascade. C. difﬁcile also contains a
skin element, skin
Cd integrated into the sigK gene [38].I n
common with B. subtilis, excision of this element in the
mother cell is required for sporulation [38]. In contrast to B.
subtilis, however, C. difﬁcile strains that do not contain the
skin element sporulate very poorly. Skin
Cd is much smaller
than the B. subtilis skin element at 14 kb and appears to be
degenerate, only retaining its site-speciﬁc recombinase
(required for excision in the mother cell). A plausible scenario
for the evolution of skin
Cd is that a prophage entered the sigK
gene in an ancestral C. difﬁcile strain and became adapted to
sense the cellular stress that is a prelude for sporulation (and
the phage lytic cycle) so that it excised and entered the lytic
cycle. It must also have had the ability to avoid excision from
the genome destined for the spore so that the prophage
genome was maintained. Further evolutionary events may
have resulted in the element losing the ability to kill the host
and further integration into the host cell's physiology.
The exact role of skin
Cd has not been determined but it may
be involved in the correct timing of SigK production [47].
However the regulatory signal that induces skin
Cd to excise
has not been determined.
7. Bacteriophages
C. difﬁcile has been shown to contain a number of different
bacteriophages; for a recent review see Hargreaves and Clokie
[48]. Three of these phages, fCD119, fCD38-2 and fCD27
are able to up- and down-regulate production of the toxins
[49e51]. In the case of fCD119, this occurs by direct binding
of a regulatory protein to the region upstream of tcdR within
the PaLoc which encodes a positive regulator of toxin pro-
duction [49].
The phage FC2 has been shown to mediate the transduction
of an MLS resistance gene contained within an MTn Tn6215
[52]. This is the ﬁrst example of transduction in C. difﬁcile
demonstrating that phage have a role in mediating the spread
of antibiotic resistance and potentially in the spread of other
genes.
Phage particles have been found in the stools of patients
infected with C. difﬁcile demonstrating that lytic phage is
produced during infection. Identical phages were found within
the genome of the infecting strain, indicating that the phages
were induced within the patients [53]. These workers also
showed that lysogens of these phages could be induced to
produce viral particles by treatment with sub-inhibitory con-
centrations of ciproﬂoxacin, moxiﬂoxacin, levoﬂoxacin, and
mitomycin C suggesting that administration of these antibi-
otics to C. difﬁcile-infected patients will promote phage
mobility.
Phages also have the potential to be used as therapy for C.
difﬁcile associated disease. They are considered particularly
Fig. 1. Comparison of part of CTn5 from C. difﬁcile 630 to the part of Tn6103 that contains the three putative MTns. The red boxes represent homologous genes
between CTn5 and Tn6103. The points of insertion of the three putative MTns are represented by the dotted lines. (Figure reproduced from; Brouwer MSM,
Warburton PJ, Roberts AP, Mullany P, Allan E. (2011) Genetic organisation, mobility and predicted functions of genes on integrated, mobile genetic elements in
sequenced strains of Clostridium difﬁcile. PLoS ONE 6(8): e23014. http://dx.doi.org/10.1371/journal.pone.0023014).
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without collateral damage to the microbiota. Phage fCD27
has been evaluated in a gut ecosystem model where it showed
promise in treatment of a model infection compared to an
untreated control [54]. However, for phages to be safely used,
we need to understand more about their biology to avoid un-
wanted side effects like the transduction of antibiotic resis-
tance genes and the up-regulation of toxin genes. Another
problem encountered with the development of phage as ther-
apeutic agents for C. difﬁcile infection, is that all of those
investigated to date form lysogens which would prevent efﬁ-
cient killing of all the infecting bacteria.
8. Transfer of the PaLoc
The PaLoc contains the genes encoding toxins A and B, the
major virulence factors of the organism [55]. In addition to
these genes, it contains a gene encoding a positive regulator of
toxin gene expression, tcdD [56], a homologue of a phage
holin, tcdE, and tcdC (see below). There is some controversy
in the role of TcdE in toxin release and its exact role requires
further experiments [57,58]. TcdC was initially proposed to be
a negative regulator of toxin production but recent genetic
evidence does not support this idea [59,60]. The PaLoc has
some of the properties of a MGE as it occupies the same
genomic location in all toxigenic strains and in non-toxigenic
strains; it is replaced with 115 bp of non-coding sequence [55].
The phage-like holin gene and regulatory interaction with
various phage also implies a relationship with MGEs [49,50].
However the element does not contain an obvious oriT, nor
does it contain any predicted recombinase genes. Despite these
observations, we have shown that the PaLoc is capable of
transfer from toxigenic to non-toxigenic strains [61].
PaLoc transfer was initially discovered when selecting for a
genetically marked copy of CTn2 from C. difﬁcile 6 3 0t oC D 3 7 .
When investigating the transconjugants for co-transfer of non-
selected genetic elements, it was found that one trans-
conjugant also contained the PaLoc. Further transfer experi-
ments with a donor bearing a PaLoc with an erythromycin
resistance gene within toxB reproducibly yielded trans-
conjugants and investigation of these showed that the PaLoc
was transferred on variable sized genomic fragments ranging
from 66 kbp to 272 kbp. This study also showed that the PaLoc
was frequently co-transferred with CTns (Fig. 2) [61].T h e
transfer frequency of PaLoc and CTn was low, approximately 1
transconjugant per 10
8 recipients however a non-selected CTn
was almost always observed in transconjugants containing the
PaLoc indicating that PaLoc and CTn transfer are linked. The
exact mechanism behind this linkage is still under investigation
however a hypothesis that explains these observations is that
that one or more of the CTns provides an integrated origin of
transfer for the transfer of large genome fragments containing
the PaLoc. We propose that if a CTn does not excise, it may
promote the transfer of large genomic fragments by CTaR.
Importantly, it was shown that the newly acquired toxin
genes were expressed in the previously non-toxigenic strain,
CD37, showing that non-toxigenic strains have the potential to
be converted to toxin producers [61]. This is an important
Fig. 2. Demonstration of transfer of the PaLoc. The left panel represents the C. difﬁcile 630 genome. The outer circle represents the C. difﬁcile genome the green
bands on the second circle represent 10 kb fragments around the 630 genome that contain snips and indels that differentiate the 630 donor genome from the CD37
recipient genome; the dark blue fragments on the third circle represents the location of CTns the red fragment on the third circle represent the location of the
PaLoc, the purple fragments on the third circle represent the location of prophage. The fourth to the tenth circle represent CD37 transconjugants containing the
PaLoc, transferred fragments are shown by coloured lines, transferred CTns and PaLocs are shown. The right hand panel shows the region containing the PaLoc in
more detail. (for more details see reference [47]). Figure reproduced from; Brouwer MS, Roberts AP, Hussain H, Williams RJ, Allan E, Mullany P. (2013).
Horizontal gene transfer converts non-toxigenic Clostridium difﬁcile strains into toxin producers. Nature Communications. 4, 2601.
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therapeutic agents for C. difﬁcile disease [62], and there is an
urgent need therefore to understand the factors promoting
transfer of the PaLoc.
9. Conclusions
C. difﬁcile contains a large number of MGEs and as we
have discussed above, these have a wide-ranging effect on the
biology of the bacterium. The major virulence factors of the
organism, toxins A and B, are contained on a genetic island,
the PaLoc, which is itself transferable on large genomic
fragments, most likely mediated by the integrated CTns. In
addition, bacteriophages can modulate expression of the toxin
genes within the PaLoc. Thus, MGEs have a profound inﬂu-
ence on the organism's pathogenicity. Further examples
include the ability of Tn5397 to insertionally target C. difﬁcile
genes containing Fic domains, which may have a role in
virulence. MGEs also affect the biology of the organism in
other ways: by spreading antibiotic resistance and other phe-
notypes enabling adaptation to stressful environments. The
fact that some MGEs encode predicted sigma factors and other
regulators indicates that these elements have the potential to
modulate the regulatory pathways of C. difﬁcile with, as yet
unknown, but potentially profound consequences on the
biology of the organism. Furthermore, the large number of
MGEs in C. difﬁcile and the genetic ﬂexibility they afford
undoubtedly contributes to the evolutionary success of this
organism.
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